Financière de Tubize SA (EBR:TUB)
Belgium · Delayed Price · Currency is EUR 195.70
+4.20 (2.19%)
Apr 30, 2026, 5:35 PM CET
Financière de Tubize Market Cap
Financière de Tubize has a market cap or net worth of €8.71 billion as of May 1, 2026. Its market cap has increased by 75.67% in one year.
Market Cap
8.71B
Enterprise Value
8.71B
Revenue
n/a
Ranking
n/a
PE Ratio
93.44
Stock Price
€195.70
Market Cap Chart
Since April 16, 2001, Financière de Tubize's market cap has increased from 1.37B to 8.71B, an increase of 535.07%. That is a compound annual growth rate of 7.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 8.71B | -6.36% |
| Dec 31, 2025 | 9.30B | 46.98% |
| Dec 31, 2024 | 6.33B | 98.33% |
| Dec 29, 2023 | 3.19B | 1.27% |
| Dec 30, 2022 | 3.15B | -21.59% |
| Dec 31, 2021 | 4.02B | 9.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 43.35B |
| argenx SE | 41.39B |
| Onward Medical | 196.07M |
| Hyloris Pharmaceuticals | 149.52M |
| European Medical Solutions | 21.16M |
| Celyad Oncology | 14.23M |
| BioSenic | 1.57M |
| Oxurion NV | 337.03K |